<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>Prostate Cancer • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="Prostate Cancer • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/prostate cancer/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/prostate cancer/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h2 id="prostate-cancer" tabindex="-1">Prostate Cancer</h2>
<!-- prostate cancer prognosis, management -->
<p><strong>Prostate cancer</strong> is widely prevalent in men age &gt;65. Most cases are slow-growing and do not result in  death. Risk stratification using digital rectal examination, PSA level, and biopsy with Gleason score can help to determine the optimal  treatment approach and prevent unnecessary treatment-related morbidity.</p>
<p>Patients with prostate cancer are generally stratified as <strong>very low-risk</strong> when the following features are present:</p>
<ul>
<li>Gleason score of &lt;6 with &lt;3 cores affected (&lt;50% involvement in each affected core)</li>
<li>Normal digital rectal examination</li>
<li>PSA &lt;10 ng/mL</li>
</ul>
<p>Patients with very low-risk (and many with low-risk) prostate cancer have <strong>excellent 10-year survival</strong> rates and should be treated with <strong>active surveillance</strong> rather than definitive therapy. Active surveillance includes  monitoring serum PSA levels every 3-6 months, having a digital rectal  examination yearly, and having a repeat prostate biopsy at the end of  year 1 to ensure that higher-grade disease was not missed on the  original biopsy.</p>
<p>Individuals who progress on  active surveillance and those with higher initial risk stratifications  (moderate, high, very high) are typically treated with radiotherapy or  radical prostatectomy. These therapies are associated with high cure  rates but often cause significant morbidity. Radiotherapy (eg,  brachytherapy, external beam) commonly results in urinary and  gastrointestinal irritation as well as erectile dysfunction <strong>(Choice C)</strong>. Radical prostatectomy is associated with high rates of sexual dysfunction and moderate rates of urinary incontinence <strong>(Choices A and D)</strong>.</p>
<p><strong>(Choice B)</strong>  Androgen deprivation therapy is not generally recommended for localized prostate cancer but is widely used for metastatic prostate cancer.  Patients with very low-risk or low-risk prostate cancer are considered  to have localized disease and do not require androgen deprivation  therapy or evaluation (eg, CT scan, bone scan) for metastatic disease.</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        <nav class="toc" >
        <ul><li><a href="#prostate-cancer">Prostate Cancer</a></li></ul>
      </nav>
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Hemeonc/" class="peer">Hemeonc</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="hemeonc" tabindex="-1">Hemeonc</h1>
<ul>
<li>Keywords:: <a href="/wiki/notes/Step%203/">Step 3</a>, <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<hr>
<h2 id="heme" tabindex="-1">Heme</h2>
<ul>
<li><a href="/wiki/notes/Bleeding%20disorders/">Bleeding disorders</a></li>
<li><a href="/wiki/notes/Anemia/">Anemia</a></li>
<li><a href="/wiki/notes/DVT%20and%20PE/">DVT and PE</a></li>
<li><a href="/wiki/notes/Hemochromatosis/">Hemochromatosis</a></li>
<li><a href="/wiki/notes/Sickle%20cell%20disease/">Sickle cell disease</a></li>
<li><a href="/wiki/notes/warfarin/">warfarin</a></li>
<li><a href="/wiki/notes/heparin%20induced%20thrombocytopenia/">heparin induced thrombocytopenia</a></li>
<li><a href="/wiki/notes/disseminated%20intravascular%20coagulation/">disseminated intravascular coagulation</a></li>
<li><a href="/wiki/notes/TTP/">TTP</a></li>
<li><a href="/wiki/notes/blood%20smear/">blood smear</a></li>
<li><a href="/wiki/notes/polycythemia%20vera/">polycythemia vera</a></li>
<li><a href="/wiki/notes/essential%20thrombocytosis/">essential thrombocytosis</a></li>
<li><a href="/wiki/notes/anemia%20lecture/">anemia lecture</a></li>
<li><a href="/wiki/notes/transfusion%20medicine/">transfusion medicine</a></li>
<li><a href="/wiki/notes/DIC%20vs%20liver%20disease/">DIC vs liver disease</a></li>
<li><a href="/wiki/notes/anticoagulation%20reversal/">anticoagulation reversal</a></li>
</ul>
<h2 id="oncology" tabindex="-1">Oncology</h2>
<ul>
<li>[[Paget d</li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
